Stephanie A. Pumphrey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Stephanie A. Pumphrey has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Stefano Pizzirani
Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA
5 shared publications- Federica Maggio
Ophthalmology Service Tufts Veterinary Emergency Treatment and Specialties Walpole Massachusetts USA
3 shared publications Nicholas A. Robinson
Department of Biomedical Sciences, Cummings School of Veterinary Medicine Tufts University North Grafton Massachusetts USA
3 shared publicationsSujata J. Desai
Department of Clinical Sciences Cummings School of Veterinary Medicine at Tufts University North Grafton Massachusetts USA
3 shared publicationsChristopher G. Pirie
Tufts Cummings School of Veterinary Medicine, 200 Westboro Road, North Grafton, MA, 01536 USA
2 shared publicationsFederica Maggio
Tufts Veterinary Emergency Treatment and Specialties, Walpole, MA
2 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- p. 1-10
Intracameral lidocaine-epinephrine has minimal effect on heart rate and blood pressure and is an effective sole mydriatic during phacoemulsification in dogs
Objective: To investigate heart rate (HR) and rhythm, blood pressure (BP), and pupil diameter in dogs that received intracameral (IC) preservative-free lidocaine-epinephrine (ILE) as a sole mydriatic agent during phacoemulsification. Methods: Records were retrospectively reviewed for HR and BP data and anesthesia concerns following administration of ILE during cataract surgery (IC group, 130 eyes from 83 dogs). Similar data were obtained for a control group undergoing phacoemulsification that received topical mydriatics (topical treatment [TT] group, 40 eyes from 21 dogs). Pupil diameter was measured prospectively following administration of ILE in an additional 20 eyes from 11 dogs. Results: Average baseline HR was 13 beats/min higher in the TT group than in the IC group for both eyes operated ( P ≤ .04). Heart rate increased more from baseline in the IC group than in the TT group at 15 and 20 minutes after administration, but the difference was not clinically significant (average of 4 beats/min). Changes in BP were minimal and did not differ between groups. No significant arrhythmias or other anesthetic complications were noted in either group. Mean pupil diameter was 11.3 mm (95% CI, 11, 11.6) immediately following ILE administration and 11.8 mm (95% CI, 11.5, 12.1) at the conclusion of surgery. Conclusions: ILE produced adequate, durable mydriasis when used as a sole mydriatic in canine eyes undergoing phacoemulsification. Intracameral lidocaine-epinephrine does not appear to affect cardiovascular parameters when administered during phacoemulsification in dogs. Clinical Relevance: ILE is a reasonable mydriatic choice for canine phacoemulsification.
- 19 November 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- p. 1-10
Open AccessIntracameral lidocaine-epinephrine has minimal effect on heart rate and blood pressure and is an effective sole mydriatic during phacoemulsification in dogs
Objective: To investigate heart rate (HR) and rhythm, blood pressure (BP), and pupil diameter in dogs that received intracameral (IC) preservative-free lidocaine-epinephrine (ILE) as a sole mydriatic agent during phacoemulsification. Methods: Records were retrospectively reviewed for HR and BP data and anesthesia concerns following administration of ILE during cataract surgery (IC group, 130 eyes from 83 dogs). Similar data were obtained for a control group undergoing phacoemulsification that received topical mydriatics (topical treatment [TT] group, 40 eyes from 21 dogs). Pupil diameter was measured prospectively following administration of ILE in an additional 20 eyes from 11 dogs. Results: Average baseline HR was 13 beats/min higher in the TT group than in the IC group for both eyes operated ( P ≤ .04). Heart rate increased more from baseline in the IC group than in the TT group at 15 and 20 minutes after administration, but the difference was not clinically significant (average of 4 beats/min). Changes in BP were minimal and did not differ between groups. No significant arrhythmias or other anesthetic complications were noted in either group. Mean pupil diameter was 11.3 mm (95% CI, 11, 11.6) immediately following ILE administration and 11.8 mm (95% CI, 11.5, 12.1) at the conclusion of surgery. Conclusions: ILE produced adequate, durable mydriasis when used as a sole mydriatic in canine eyes undergoing phacoemulsification. Intracameral lidocaine-epinephrine does not appear to affect cardiovascular parameters when administered during phacoemulsification in dogs. Clinical Relevance: ILE is a reasonable mydriatic choice for canine phacoemulsification.
- Open Access
- 14 April 2026
- Published by SAGE Publications in Journal of Feline Medicine and Surgery
- Vol. 28 (5)
Treatment rationales and outcomes for cats with lens luxation: 136 eyes (2007–2023)
Objectives: The aim of the present study was to evaluate outcomes in cats with lens luxation treated with intracapsular lens extraction (ICLE), medical management or transcorneal lens reduction (TCLR), and to investigate the reasoning behind treatment recommendations. Methods: Medical records were retrospectively reviewed to identify cats with lens luxation. Data collected included signalment, examination findings, treatment decision and rationale for treatment, and outcome. Results: Records were reviewed for 136 eyes from 115 cats. Male cats (77%) were overrepresented. Of the eyes, 83/136 (61%) were non-visual on presentation. Medical management was initially elected for 79/136 (58%) eyes, enucleation for 32/136 (24%), ICLE for 12/136 (9%) and TCLR for 7/136 (5%), while no treatment was elected for 3/136 (2%) eyes. Two cats were euthanized (2/136 eyes, 1%) and one eye underwent diode laser cyst ablation. TCLR was not successful in any eyes. Of eyes with follow-up, 12/13 (92%) eyes that underwent ICLE as primary or secondary management were visual and normotensive (intraocular pressure [IOP] <25 mmHg), while 19/50 (38%) medically managed eyes were visual and normotensive. However, 33/50 (66%) medically managed eyes were normotensive at last recheck and 17/23 (74%) medically managed eyes that were visual on presentation remained visual at last recheck. Treatment rationale was noted for 94 eyes. Factors cited included visual status (40%), perceived comfort (36%), age or medical history (29%), financial limitations (12%), inability to medicate (10%), other ocular examination findings (9%) and potential risk of feline post-traumatic ocular sarcoma after ICLE (7%). Conclusions and relevance: TCLR does not appear to be a viable treatment modality in cats. Medical management of lens luxation may produce acceptable results for IOP control and retention of vision when ICLE is not possible. Providing cat owners with accurate information about outcomes and financial implications of treatment options for lens luxation is critical.
- 14 April 2026
- Published by SAGE Publications in Journal of Feline Medicine and Surgery
- Vol. 28 (5)
Open AccessTreatment rationales and outcomes for cats with lens luxation: 136 eyes (2007–2023)
Objectives: The aim of the present study was to evaluate outcomes in cats with lens luxation treated with intracapsular lens extraction (ICLE), medical management or transcorneal lens reduction (TCLR), and to investigate the reasoning behind treatment recommendations. Methods: Medical records were retrospectively reviewed to identify cats with lens luxation. Data collected included signalment, examination findings, treatment decision and rationale for treatment, and outcome. Results: Records were reviewed for 136 eyes from 115 cats. Male cats (77%) were overrepresented. Of the eyes, 83/136 (61%) were non-visual on presentation. Medical management was initially elected for 79/136 (58%) eyes, enucleation for 32/136 (24%), ICLE for 12/136 (9%) and TCLR for 7/136 (5%), while no treatment was elected for 3/136 (2%) eyes. Two cats were euthanized (2/136 eyes, 1%) and one eye underwent diode laser cyst ablation. TCLR was not successful in any eyes. Of eyes with follow-up, 12/13 (92%) eyes that underwent ICLE as primary or secondary management were visual and normotensive (intraocular pressure [IOP] <25 mmHg), while 19/50 (38%) medically managed eyes were visual and normotensive. However, 33/50 (66%) medically managed eyes were normotensive at last recheck and 17/23 (74%) medically managed eyes that were visual on presentation remained visual at last recheck. Treatment rationale was noted for 94 eyes. Factors cited included visual status (40%), perceived comfort (36%), age or medical history (29%), financial limitations (12%), inability to medicate (10%), other ocular examination findings (9%) and potential risk of feline post-traumatic ocular sarcoma after ICLE (7%). Conclusions and relevance: TCLR does not appear to be a viable treatment modality in cats. Medical management of lens luxation may produce acceptable results for IOP control and retention of vision when ICLE is not possible. Providing cat owners with accurate information about outcomes and financial implications of treatment options for lens luxation is critical.
- 9 June 2025
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (1)
Factors Influencing the Incidence and Onset of Primary Angle‐Closure Glaucoma in the Unaffected Eye of Dogs
Objective: To determine factors that may affect the onset of glaucoma in the unaffected, contralateral eye of dogs with primary angle‐closure glaucoma (PACG). Animal Studied: One hundred and seventeen dogs unilaterally affected by PACG. Procedures: Multicenter retrospective study. Patient factors, examination findings, prophylactic treatments, and treatment failure dates were recorded. Treatment failure was defined as glaucoma onset in the contralateral eye (IOP > 25 mmHg); death prior to a second diagnosis was treated as a competing risk. Cumulative incidence plots and Cox proportional hazard models were used to visualize and test for associations between baseline characteristics and time to treatment failure. Results: Mean age at first diagnosis was 8.3 years and 69.2% were female. Within 5 years, 70.9% of dogs with unilateral PACG developed glaucoma in the contralateral eye. Median time to treatment failure was 2.15 years. The most common purebred dogs were the Cocker Spaniel, Basset Hound, and Shih Tzu. Dogs with an initial diagnosis in the left eye had a 1.8‐fold increased risk of treatment failure of the right eye. Time to treatment failure was not different between dogs receiving prophylactic topical carbonic anhydrase inhibitors versus beta‐blockers, nor in dogs receiving versus not receiving topical corticosteroids. Conclusions: No treatment regimen was found to be superior to another for PACG prophylaxis. Future prospective studies are warranted to investigate complementary glaucoma management strategies.
- 9 June 2025
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (1)
Factors Influencing the Incidence and Onset of Primary Angle‐Closure Glaucoma in the Unaffected Eye of Dogs
Objective: To determine factors that may affect the onset of glaucoma in the unaffected, contralateral eye of dogs with primary angle‐closure glaucoma (PACG). Animal Studied: One hundred and seventeen dogs unilaterally affected by PACG. Procedures: Multicenter retrospective study. Patient factors, examination findings, prophylactic treatments, and treatment failure dates were recorded. Treatment failure was defined as glaucoma onset in the contralateral eye (IOP > 25 mmHg); death prior to a second diagnosis was treated as a competing risk. Cumulative incidence plots and Cox proportional hazard models were used to visualize and test for associations between baseline characteristics and time to treatment failure. Results: Mean age at first diagnosis was 8.3 years and 69.2% were female. Within 5 years, 70.9% of dogs with unilateral PACG developed glaucoma in the contralateral eye. Median time to treatment failure was 2.15 years. The most common purebred dogs were the Cocker Spaniel, Basset Hound, and Shih Tzu. Dogs with an initial diagnosis in the left eye had a 1.8‐fold increased risk of treatment failure of the right eye. Time to treatment failure was not different between dogs receiving prophylactic topical carbonic anhydrase inhibitors versus beta‐blockers, nor in dogs receiving versus not receiving topical corticosteroids. Conclusions: No treatment regimen was found to be superior to another for PACG prophylaxis. Future prospective studies are warranted to investigate complementary glaucoma management strategies.
- 19 November 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 52 (1) , 53-60
The effect of intravenous hydromorphone alone or in combination with midazolam or dexmedetomidine on intraocular pressure in dogs
- 19 November 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 52 (1) , 53-60
The effect of intravenous hydromorphone alone or in combination with midazolam or dexmedetomidine on intraocular pressure in dogs
- 20 November 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 27 (1) , 70-78
Quantifying refractive error in companion dogs with and without nuclear sclerosis: 229 eyes from 118 dogs
Objective: To evaluate the relationship between nuclear sclerosis (NS) and refractive error in companion dogs.Animals studied: One hundred and eighteen companion dogs.Procedures: Dogs were examined and found to be free of significant ocular abnormalities aside from NS. NS was graded from 0 (absent) to 3 (severe) using a scale developed by the investigators. Manual refraction was performed. The effect of NS grade on refractive error was measured using a linear mixed effects analysis adjusted for age. The proportion of eyes with >1.5 D myopia in each NS grade was evaluated using a chi‐square test. Visual impairment score (VIS) was obtained for a subset of dogs and compared against age, refractive error, and NS grade.Results: Age was strongly correlated with NS grade (p < .0001). Age‐adjusted analysis of NS grade relative to refraction showed a mild but not statistically significant increase in myopia with increasing NS grade, with eyes with grade 3 NS averaging 0.58–0.88 D greater myopia than eyes without NS. However, the myopia of >1.5 D was documented in 4/58 (6.9%) eyes with grade 0 NS, 12/91 (13.2%) eyes with grade 1 NS, 13/57 (22.8%) eyes with grade 2 NS, and 7/23 (30.4%) eyes with grade 3 NS. Risk of myopia >1.5 D was significantly associated with increasing NS grade (p = .02). VIS was associated weakly with refractive error, moderately with age, and significantly with NS grade.Conclusions: NS is associated with visual deficits in some dogs but is only weakly associated with myopia. More work is needed to characterize vision in aging dogs.
- 20 November 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 27 (1) , 70-78
Quantifying refractive error in companion dogs with and without nuclear sclerosis: 229 eyes from 118 dogs
Objective: To evaluate the relationship between nuclear sclerosis (NS) and refractive error in companion dogs.Animals studied: One hundred and eighteen companion dogs.Procedures: Dogs were examined and found to be free of significant ocular abnormalities aside from NS. NS was graded from 0 (absent) to 3 (severe) using a scale developed by the investigators. Manual refraction was performed. The effect of NS grade on refractive error was measured using a linear mixed effects analysis adjusted for age. The proportion of eyes with >1.5 D myopia in each NS grade was evaluated using a chi‐square test. Visual impairment score (VIS) was obtained for a subset of dogs and compared against age, refractive error, and NS grade.Results: Age was strongly correlated with NS grade (p < .0001). Age‐adjusted analysis of NS grade relative to refraction showed a mild but not statistically significant increase in myopia with increasing NS grade, with eyes with grade 3 NS averaging 0.58–0.88 D greater myopia than eyes without NS. However, the myopia of >1.5 D was documented in 4/58 (6.9%) eyes with grade 0 NS, 12/91 (13.2%) eyes with grade 1 NS, 13/57 (22.8%) eyes with grade 2 NS, and 7/23 (30.4%) eyes with grade 3 NS. Risk of myopia >1.5 D was significantly associated with increasing NS grade (p = .02). VIS was associated weakly with refractive error, moderately with age, and significantly with NS grade.Conclusions: NS is associated with visual deficits in some dogs but is only weakly associated with myopia. More work is needed to characterize vision in aging dogs.
- 1 September 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 27 (3) , 238-247
Relative ability of aqueous humor from dogs with and without primary angle‐closure glaucoma and ADAMTS10 open‐angle glaucoma to catalyze or inhibit collagenolysis
Objective: The objective of the study was to compare the ability of aqueous humor (AH) from dogs with primary angle‐closure glaucoma (CPACG), companion dogs without overt evidence of CPACG, and Beagles with and without ADAMTS10 open‐angle glaucoma (ADAMTS10‐OAG) to catalyze or inhibit collagenolysis.Animals studied: Seventeen normal pet dogs, 27 dogs with CPACG, 19 Beagles with ADAMTS10‐OAG, and 4 unaffected Beagles.Procedures: A fluorescein‐based substrate degradation assay was used to assess AH proteolytic capacity. Samples were then assayed using the same substrate degradation assay, with recombinant activated matrix metalloproteinase‐2 (MMP‐2) added to measure protease inhibition effects.Results: For the protease activity assay, relative fluorescence (RF) for AH from normal pet dogs was 13.28 ± 2.25% of control collagenase while RF for AH from dogs with CPACG was 17.47 ± 4.67%; RF was 8.57 ± 1.72% for ADAMTS10‐OAG Beagles and 7.99 ± 1.15% for unaffected Beagles. For the MMP‐2 inhibition assay, RF for AH from normal dogs was 34.96 ± 15.04% compared to MMP‐2 controls, while RF from dogs with CPACG was 16.69 ± 7.95%; RF was 85.85 ± 13.23% for Beagles with ADAMTS10‐OAG and 94.51 ± 8.36% for unaffected Beagles. Significant differences were found between dogs with CPACG and both normal pet dogs and dogs with ADAMTS10‐OAG and between normal pet dogs and both groups of Beagles.Conclusions: AH from dogs with CPACG is significantly more able to catalyze proteolysis and inhibit MMP‐2 than AH from normal dogs or dogs with ADAMTS10‐OAG. Results suggest that pathogenesis may differ between CPACG and ADAMTS10‐OAG.
- 1 September 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 27 (3) , 238-247
Relative ability of aqueous humor from dogs with and without primary angle‐closure glaucoma and ADAMTS10 open‐angle glaucoma to catalyze or inhibit collagenolysis
Objective: The objective of the study was to compare the ability of aqueous humor (AH) from dogs with primary angle‐closure glaucoma (CPACG), companion dogs without overt evidence of CPACG, and Beagles with and without ADAMTS10 open‐angle glaucoma (ADAMTS10‐OAG) to catalyze or inhibit collagenolysis.Animals studied: Seventeen normal pet dogs, 27 dogs with CPACG, 19 Beagles with ADAMTS10‐OAG, and 4 unaffected Beagles.Procedures: A fluorescein‐based substrate degradation assay was used to assess AH proteolytic capacity. Samples were then assayed using the same substrate degradation assay, with recombinant activated matrix metalloproteinase‐2 (MMP‐2) added to measure protease inhibition effects.Results: For the protease activity assay, relative fluorescence (RF) for AH from normal pet dogs was 13.28 ± 2.25% of control collagenase while RF for AH from dogs with CPACG was 17.47 ± 4.67%; RF was 8.57 ± 1.72% for ADAMTS10‐OAG Beagles and 7.99 ± 1.15% for unaffected Beagles. For the MMP‐2 inhibition assay, RF for AH from normal dogs was 34.96 ± 15.04% compared to MMP‐2 controls, while RF from dogs with CPACG was 16.69 ± 7.95%; RF was 85.85 ± 13.23% for Beagles with ADAMTS10‐OAG and 94.51 ± 8.36% for unaffected Beagles. Significant differences were found between dogs with CPACG and both normal pet dogs and dogs with ADAMTS10‐OAG and between normal pet dogs and both groups of Beagles.Conclusions: AH from dogs with CPACG is significantly more able to catalyze proteolysis and inhibit MMP‐2 than AH from normal dogs or dogs with ADAMTS10‐OAG. Results suggest that pathogenesis may differ between CPACG and ADAMTS10‐OAG.
- 1 November 2022
- Published by American Animal Hospital Association in Journal of the American Animal Hospital Association
- Vol. 58 (6) , 277-282
Ocular Injuries Related to Grooming Visits in Dogs: 161 Cases (2004–2020)
Owners of dogs with ocular issues often suspect their pet’s eye problems are linked to recent grooming visits. A medical records search was performed to identify dogs presenting with ocular complaints initially noted within 24 hr of a commercial grooming appointment. Data collected included signalment, type of injury, treatment, and notations regarding behavioral issues potentially contributing to injury. One hundred sixty-one episodes involving 159 dogs were identified. Male dogs accounted for 57% of episodes. Median age at presentation was 59 mo. Shih tzu were involved in 34% of incidents, and 71% involved small-breed dogs. Aggressive or reactive behaviors were reported in 33% of dogs. Corneal ulceration was the most common injury (71% of incidents), followed by conjunctivitis (11%), eyelid lacerations (7%), and subconjunctival hemorrhage (6%). Surgical management was required in 14% of cases, including four dogs that underwent enucleation. Ocular injury during grooming appointments can occur via several mechanisms including trauma, exposure to grooming products, or inadvertent strangulation. Small-breed dogs, particularly shih tzu, appear to be at increased risk. Reactive or aggressive behavior likely increases risk of ocular injury. Veterinarians can help limit grooming-associated ocular injuries by recommending behavioral or pharmacological interventions before grooming visits.
- 1 November 2022
- Published by American Animal Hospital Association in Journal of the American Animal Hospital Association
- Vol. 58 (6) , 277-282
Ocular Injuries Related to Grooming Visits in Dogs: 161 Cases (2004–2020)
Owners of dogs with ocular issues often suspect their pet’s eye problems are linked to recent grooming visits. A medical records search was performed to identify dogs presenting with ocular complaints initially noted within 24 hr of a commercial grooming appointment. Data collected included signalment, type of injury, treatment, and notations regarding behavioral issues potentially contributing to injury. One hundred sixty-one episodes involving 159 dogs were identified. Male dogs accounted for 57% of episodes. Median age at presentation was 59 mo. Shih tzu were involved in 34% of incidents, and 71% involved small-breed dogs. Aggressive or reactive behaviors were reported in 33% of dogs. Corneal ulceration was the most common injury (71% of incidents), followed by conjunctivitis (11%), eyelid lacerations (7%), and subconjunctival hemorrhage (6%). Surgical management was required in 14% of cases, including four dogs that underwent enucleation. Ocular injury during grooming appointments can occur via several mechanisms including trauma, exposure to grooming products, or inadvertent strangulation. Small-breed dogs, particularly shih tzu, appear to be at increased risk. Reactive or aggressive behavior likely increases risk of ocular injury. Veterinarians can help limit grooming-associated ocular injuries by recommending behavioral or pharmacological interventions before grooming visits.
- 8 April 2022
- Published by Wiley in Veterinary Ophthalmology
- Vol. 25 (5) , 343-349
Retrospective evaluation of canine primary, multicentric, and metastatic intraocular neoplasia
Objective: To provide an updated characterization of the prevalence of primary, multicentric, and metastatic intraocular tumors in the canine patient.Procedures: Medical records databases from 4 veterinary referral hospitals were reviewed from 1999 to present to identify dogs with a diagnosis of intraocular neoplasia histopathologically confirmed following enucleation or necropsy.Results: One hundred seventy‐two dogs with 173 intraocular neoplasms met the inclusion criteria. Primary intraocular neoplasms were the most common tumors in the study (128); the two most common types were melanocytic neoplasia (90), followed by iridociliary neoplasia (33). There were 28 cases of intraocular involvement secondary to round cell neoplasia, with 18 cases of lymphoma, seven histiocytic sarcomas, and three undifferentiated round cell neoplasms. There were 17 cases of metastatic intraocular neoplasia, with hemangiosarcoma being the most common (9).Conclusions: The majority of intraocular tumors in dogs arise from the ocular tissues. However, the eye may also be involved in patients with multicentric neoplasia, and, less commonly, as a site for metastatic disease. Ocular screening for patients with multicentric neoplasia should be considered during staging, and ocular signs should be viewed with suspicion in dogs with neoplasia in other sites.
- 8 April 2022
- Published by Wiley in Veterinary Ophthalmology
- Vol. 25 (5) , 343-349
Retrospective evaluation of canine primary, multicentric, and metastatic intraocular neoplasia
Objective: To provide an updated characterization of the prevalence of primary, multicentric, and metastatic intraocular tumors in the canine patient.Procedures: Medical records databases from 4 veterinary referral hospitals were reviewed from 1999 to present to identify dogs with a diagnosis of intraocular neoplasia histopathologically confirmed following enucleation or necropsy.Results: One hundred seventy‐two dogs with 173 intraocular neoplasms met the inclusion criteria. Primary intraocular neoplasms were the most common tumors in the study (128); the two most common types were melanocytic neoplasia (90), followed by iridociliary neoplasia (33). There were 28 cases of intraocular involvement secondary to round cell neoplasia, with 18 cases of lymphoma, seven histiocytic sarcomas, and three undifferentiated round cell neoplasms. There were 17 cases of metastatic intraocular neoplasia, with hemangiosarcoma being the most common (9).Conclusions: The majority of intraocular tumors in dogs arise from the ocular tissues. However, the eye may also be involved in patients with multicentric neoplasia, and, less commonly, as a site for metastatic disease. Ocular screening for patients with multicentric neoplasia should be considered during staging, and ocular signs should be viewed with suspicion in dogs with neoplasia in other sites.
- 5 March 2022
- Published by Wiley in Veterinary Ophthalmology
- Vol. 25 (4) , 282-290
Comparative effects of latanoprost and latanoprostene bunod on intraocular pressure and pupil size in ophthalmologically normal Beagle dogs
Objective To compare effects of latanoprost, a topical prostaglandin analogue (PGA) commonly used to treat glaucoma and lens instability in dogs, and latanoprostene bunod, a novel PGA with a nitric oxide-donating moiety, on intraocular pressure (IOP) and pupil diameter (PD). Animals studied Ten ophthalmologically normal Beagle dogs. Procedures Dogs were treated twice a day for 5 days in a randomly selected eye with either latanoprost or latanoprostene bunod. After a 6-week washout period, dogs were treated with the opposite drug. IOP and PD were measured at treatment times, at midday on days 1 and 5, and for 6 days post-treatment. Results Both drugs significantly decreased IOP and PD. At midday on day 5 of treatment, mean IOP in eyes treated with latanoprost was 4.5 mmHg lower than the fellow eye and 3.0 mmHg lower than the same eye at baseline, while mean IOP in eyes treated with latanoprostene bunod was 5.5 mmHg lower than the fellow eye and 3.6 mmHg lower than baseline. Mean PD was 0.94 mm in eyes treated with latanoprost and 0.76 mmHg in eyes treated with latanoprostene bunod. There was no significant difference between the two drugs for either parameter at that time point (p = .372 and .619, respectively, for IOP relative to control and to baseline; p = .076 for PD) or when analyzed longitudinally. Significant diurnal variation in PD was noted and may have implications for treatment of lens' instability. Conclusions Latanoprost and latanoprostene bunod produce similar IOP reduction and miosis in normal canine eyes.
- 5 March 2022
- Published by Wiley in Veterinary Ophthalmology
- Vol. 25 (4) , 282-290
Comparative effects of latanoprost and latanoprostene bunod on intraocular pressure and pupil size in ophthalmologically normal Beagle dogs
Objective To compare effects of latanoprost, a topical prostaglandin analogue (PGA) commonly used to treat glaucoma and lens instability in dogs, and latanoprostene bunod, a novel PGA with a nitric oxide-donating moiety, on intraocular pressure (IOP) and pupil diameter (PD). Animals studied Ten ophthalmologically normal Beagle dogs. Procedures Dogs were treated twice a day for 5 days in a randomly selected eye with either latanoprost or latanoprostene bunod. After a 6-week washout period, dogs were treated with the opposite drug. IOP and PD were measured at treatment times, at midday on days 1 and 5, and for 6 days post-treatment. Results Both drugs significantly decreased IOP and PD. At midday on day 5 of treatment, mean IOP in eyes treated with latanoprost was 4.5 mmHg lower than the fellow eye and 3.0 mmHg lower than the same eye at baseline, while mean IOP in eyes treated with latanoprostene bunod was 5.5 mmHg lower than the fellow eye and 3.6 mmHg lower than baseline. Mean PD was 0.94 mm in eyes treated with latanoprost and 0.76 mmHg in eyes treated with latanoprostene bunod. There was no significant difference between the two drugs for either parameter at that time point (p = .372 and .619, respectively, for IOP relative to control and to baseline; p = .076 for PD) or when analyzed longitudinally. Significant diurnal variation in PD was noted and may have implications for treatment of lens' instability. Conclusions Latanoprost and latanoprostene bunod produce similar IOP reduction and miosis in normal canine eyes.
- 1 March 2022
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 83 (3) , 245-255
Evaluation of matrix metalloproteinases and tissue inhibitors of metalloproteinases in aqueous humor of dogs with versus without naturally occurring primary angle-closure glaucoma
OBJECTIVE: To compare concentrations of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in aqueous humor from ophthalmologically normal dogs and dogs with naturally occurring primary angle-closure glaucoma (cPACG). SAMPLE: Aqueous humor samples from 12 eyes with cPACG and 18 ophthalmologically normal eyes of dogs. PROCEDURES: A multiplex fluorescence-based ELISA was used to measure concentrations of MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13, TIMP-1, TIMP-2, and TIMP-4. Results for eyes with versus without cPACG were compared. RESULTS: Significantly higher mean concentrations of MMP-1 (45% higher), MMP-2 (55% higher), MMP-3 (39% higher), MMP-8 (79% higher), MMP-9 (29% higher), MMP-10 (60% higher), TIMP-1 (63% higher), and TIMP-2 (136% higher) were detected in aqueous humor from eyes with cPACG, compared with ophthalmologically normal eyes. CLINICAL RELEVANCE: MMPs and TIMPs have pivotal roles in extracellular matrix turnover and homeostasis in the outflow pathways of the eye. Results of the present study documented higher concentrations of MMPs and TIMPs in aqueous humor samples from dog eyes with late-stage cPACG. Although, to our knowledge, TIMPs have not previously been evaluated in the context of cPACG, the markedly higher concentration of TIMPs in eyes with cPACG suggested that inhibition of proteolysis and extracellular matrix turnover might be a factor in the development of glaucoma in susceptible individuals. However, because the present study used samples from dogs with late-stage cPACG, further work is required to characterize the temporal relationship between MMP and TIMP concentration changes and onset or progression of disease.
- 1 March 2022
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 83 (3) , 245-255
Evaluation of matrix metalloproteinases and tissue inhibitors of metalloproteinases in aqueous humor of dogs with versus without naturally occurring primary angle-closure glaucoma
OBJECTIVE: To compare concentrations of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in aqueous humor from ophthalmologically normal dogs and dogs with naturally occurring primary angle-closure glaucoma (cPACG). SAMPLE: Aqueous humor samples from 12 eyes with cPACG and 18 ophthalmologically normal eyes of dogs. PROCEDURES: A multiplex fluorescence-based ELISA was used to measure concentrations of MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13, TIMP-1, TIMP-2, and TIMP-4. Results for eyes with versus without cPACG were compared. RESULTS: Significantly higher mean concentrations of MMP-1 (45% higher), MMP-2 (55% higher), MMP-3 (39% higher), MMP-8 (79% higher), MMP-9 (29% higher), MMP-10 (60% higher), TIMP-1 (63% higher), and TIMP-2 (136% higher) were detected in aqueous humor from eyes with cPACG, compared with ophthalmologically normal eyes. CLINICAL RELEVANCE: MMPs and TIMPs have pivotal roles in extracellular matrix turnover and homeostasis in the outflow pathways of the eye. Results of the present study documented higher concentrations of MMPs and TIMPs in aqueous humor samples from dog eyes with late-stage cPACG. Although, to our knowledge, TIMPs have not previously been evaluated in the context of cPACG, the markedly higher concentration of TIMPs in eyes with cPACG suggested that inhibition of proteolysis and extracellular matrix turnover might be a factor in the development of glaucoma in susceptible individuals. However, because the present study used samples from dogs with late-stage cPACG, further work is required to characterize the temporal relationship between MMP and TIMP concentration changes and onset or progression of disease.